1. Home
  2. IVVD vs EM Comparison

IVVD vs EM Comparison

Compare IVVD & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • EM
  • Stock Information
  • Founded
  • IVVD 2020
  • EM 2017
  • Country
  • IVVD United States
  • EM China
  • Employees
  • IVVD N/A
  • EM N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • EM Other Consumer Services
  • Sector
  • IVVD Health Care
  • EM Consumer Discretionary
  • Exchange
  • IVVD Nasdaq
  • EM Nasdaq
  • Market Cap
  • IVVD 351.6M
  • EM 286.5M
  • IPO Year
  • IVVD 2021
  • EM 2021
  • Fundamental
  • Price
  • IVVD $1.61
  • EM $1.37
  • Analyst Decision
  • IVVD Strong Buy
  • EM Hold
  • Analyst Count
  • IVVD 5
  • EM 1
  • Target Price
  • IVVD $6.11
  • EM $1.25
  • AVG Volume (30 Days)
  • IVVD 6.2M
  • EM 865.7K
  • Earning Date
  • IVVD 11-07-2025
  • EM 11-26-2025
  • Dividend Yield
  • IVVD N/A
  • EM N/A
  • EPS Growth
  • IVVD N/A
  • EM N/A
  • EPS
  • IVVD N/A
  • EM N/A
  • Revenue
  • IVVD $46,210,000.00
  • EM $259,541,587.00
  • Revenue This Year
  • IVVD $102.11
  • EM $3.30
  • Revenue Next Year
  • IVVD $151.51
  • EM $5.26
  • P/E Ratio
  • IVVD N/A
  • EM N/A
  • Revenue Growth
  • IVVD 1941.08
  • EM N/A
  • 52 Week Low
  • IVVD $0.35
  • EM $0.59
  • 52 Week High
  • IVVD $2.74
  • EM $1.45
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 46.79
  • EM 61.82
  • Support Level
  • IVVD $1.74
  • EM $1.28
  • Resistance Level
  • IVVD $2.00
  • EM $1.41
  • Average True Range (ATR)
  • IVVD 0.24
  • EM 0.03
  • MACD
  • IVVD -0.06
  • EM 0.00
  • Stochastic Oscillator
  • IVVD 1.33
  • EM 69.23

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

Share on Social Networks: